Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalfurafine Hydrochloride OD Tablets for Refractory Pruritus in Chronic Liver Disease
CTR20260357Phase 3Active
- Sponsor
- Toray Industries
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of paroxetine in cholestatic pruritus (2 arms), sponsored by Toray Industries. Started Feb 2026; status: active.
02
Drugs
paroxetine
03
Conditions
cholestatic pruritus
Beyond the preview
Go deeper on CTR20260357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260357.